Role of endocytic uptake in transfection efficiency of solid lipid nanoparticles-based nonviral vectors

Journal of Gene Medicine

Volumn 15, Issue 11-12, 2013, Pages 427-440

  Ruiz de Garibay, Aritz Perez ^a   Solinís Aspiazu, María Ángeles ^a   Rodríguez Gascón, Alicia ^a   Ganjian, Haleh ^b   Fuchs, Renate ^b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Endocytosis; Lysosome; Nonviral vector; Solid lipid nanoparticles; Transfection

Indexed keywords

5 (N ETHYL N ISOPROPYL)AMILORIDE; SOLID LIPID NANOPARTICLE;

ARTICLE; CELL MEMBRANE; CELL VIABILITY; CONTROLLED STUDY; ENDOCYTOSIS; GENE EXPRESSION; GENETIC TRANSFECTION; GOLGI COMPLEX; HELA CELL; HUMAN; HUMAN CELL; INTERNALIZATION; INTRACELLULAR TRANSPORT; PARTICLE SIZE; PINOCYTOSIS; PRIORITY JOURNAL; SURFACE CHARGE;

ENDOCYTOSIS; LYSOSOME; NONVIRAL VECTOR; SOLID LIPID NANOPARTICLES; TRANSFECTION;

AMMONIUM CHLORIDE; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; ENDOCYTOSIS; ENDOSOMES; GENE EXPRESSION; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LIPIDS; NANOPARTICLES; PARTICLE SIZE; STATIC ELECTRICITY; TRANSFECTION;

EID: 84891082011     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.2749     Document Type: Article

References (52)

1. Cross D, Burmester JK. Gene therapy for cancer treatment: past, present and future. Clin Med Res 2006; 4: 218-227.
2. Ortiz R, Melguizo C, Prados J, et al. New gene therapy strategies for cancer treatment: a review of recent patents. Recent Pat Anticancer Drug Discov 2012; 7: 297-312.
3. Liu MM, Tuo J, Chan CC. Republished review: gene therapy for ocular diseases. Postgrad Med J 2011; 87: 487-495.
4. Ruiz de Garibay AP, Solinis MA, Rodriguez-Gascon A. Gene therapy for fabry disease: a review of the literature. BioDrugs 2013; 27: 237-46.
5. del Pozo-Rodriguez A, Delgado D, Solinis MA, Gascon AR, Pedraz JL. Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in RPE cells. Int J Pharm 2008; 360: 177-183.
6. del Pozo-Rodriguez A, Pujals S, Delgado D, et al. A proline-rich peptide improves cell transfection of solid lipid nanoparticle-based non-viral vectors. J Control Release 2009; 133: 52-59.
7. del Pozo-Rodriguez A, Delgado D, Solinis MA, et al. Solid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administration. Int J Pharm 2010; 385: 157-162.
8. Delgado D, Del Pozo-Rodriguez A, Solinis MA, Rodriguez-Gascon A. Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway. Eur J Pharm Biopharm 2011; 79: 495-502.
9. Delgado D, Gascón AR, del Pozo-Rodríguez A, et al. Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: in vitro characterization and in vivo transfection after intravenous administration to mice. Int J Pharm 2012; 425: 35-43.
10. Delgado D, Del Pozo-Rodriguez A, Solinis MA, et al. Dextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X-linked juvenile retinoschisis. Hum Gene Ther 2012; 23: 345-355.
11. Ruiz de Garibay AP, Delgado D, Del Pozo-Rodriguez A, Solinis MA, Gascon AR. Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy. Drug Des Devel Ther 2012; 6: 303-310.
12. von Gersdorff K, Sanders NN, Vandenbroucke R, De Smedt SC, Wagner E, Ogris M. The internalization route resulting in successful gene expression depends on both cell line and polyethylenimine polyplex type. Mol Ther 2006; 14: 745-753.
13. Duncan R, Richardson SC. Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges. Mol Pharm 2012; 9: 2380-2402.
14. Kumari S, Mg S, Mayor S. Endocytosis unplugged: multiple ways to enter the cell. Cell Res 2010; 20: 256-275.
15. Mercer J, Schelhaas M, Helenius A. Virus entry by endocytosis. Annu Rev Biochem 2010; 79: 803-833.
16. Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J Control Release 2010; 145: 182-195.
17. Mercer J, Helenius A. Gulping rather than sipping: macropinocytosis as a way of virus entry. Curr Opin Microbiol 2012; 15: 490-499.
18. Clague MJ, Urbe S, Aniento F, Gruenberg J. Vacuolar ATPase activity is required for endosomal carrier vesicle formation. J Biol Chem 1994; 269: 21-24.
19. del Pozo-Rodriguez A, Delgado D, Solinis MA, Gascon AR, Pedraz JL. Solid lipid nanoparticles: formulation factors affecting cell transfection capacity. Int J Pharm 2007; 339: 261-268.
20. Wilson JK, Sargent JM, Elgie AW, Hill JG, Taylor CG. A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy. Br J Cancer 1990; 62: 189-94.
21. Huber M, Brabec M, Bayer N, Blaas D, Fuchs R. Elevated endosomal pH in HeLa cells overexpressing mutant dynamin can affect infection by pH-sensitive viruses. Traffic 2001; 2: 727-36.
22. Khan AG, Pickl-Herk A, Gajdzik L, Marlovits TC, Fuchs R, Blaas D. Entry of a heparan sulphate-binding HRV8 variant strictly depends on dynamin but not on clathrin, caveolin, and flotillin. Virology 2011; 412: 55-67.
23. Bolte S, Cordelieres FP. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 2006; 224: 213-232.
24. Zinchuk V, Grossenbacher-Zinchuk O. Quantitative colocalization analysis of confocal fluorescence microscopy images. Curr Protoc Cell Biol 2011; 4: 19.
25. Snyers L, Zwickl H, Blaas D. Human rhinovirus type 2 is internalized by clathrin-mediated endocytosis. J Virol 2003; 77: 5360-5369.
26. Heikkila O, Susi P, Tevaluoto T, et al. Internalization of coxsackievirus A9 is mediated by {beta}2-microglobulin, dynamin, and Arf6 but not by caveolin-1 or clathrin. J Virol 2010; 84: 3666-3681.
27. Orlandi PA, Fishman PH. Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol 1998; 141: 905-915.
28. Vercauteren D, Vandenbroucke RE, Jones AT, et al. The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls. Mol Ther 2010; 18: 561-9.
29. von Kleist L, Stahlschmidt W, Bulut H, et al. Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell 2011; 146: 471-484.
30. Dutta D, Williamson CD, Cole NB, Donaldson JG. Pitstop 2 is a potent inhibitor of clathrin-independent endocytosis. PLoS One 2012; 7: e45799.
31. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 2006; 10: 839-850.
32. Wang LH, Rothberg KG, Anderson RG. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 1993; 123: 1107-1117.
33. Schnitzer JE, Oh P, Pinney E, Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol 1994; 127: 1217-1232.
34. Nonnenmacher M, Weber T. Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway. Cell Host Microbe 2011; 10: 563-576.
35. Swanson JA, Watts C. Macropinocytosis. Trends Cell Biol 1995; 5: 424-428.
36. Koivusalo M, Welch C, Hayashi H, et al. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol 2010; 188: 547-563.
37. Bartlett JS, Wilcher R, Samulski RJ. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J Virol 2000; 74: 2777-2785.
38. Yang L, Shang L, Nienhaus GU. Mechanistic aspects of fluorescent gold nanocluster internalization by live HeLa cells. Nanoscale 2013; 5: 1537-1543.
39. Uherek C, Fominaya J, Wels W. A modular DNA carrier protein based on the structure of diphtheria toxin mediates target cell-specific gene delivery. J Biol Chem 1998; 273: 8835-8841.
40. You JO, Auguste DT. The effect of swelling and cationic character on gene transfection by pH-sensitive nanocarriers. Biomaterials 2010; 31: 6859-6866.
41. Chen H, Zhang H, Thor D, Rahimian R, Guo X. Novel pH-sensitive cationic lipids with linear ortho ester linkers for gene delivery. Eur J Med Chem 2012; 52: 159-172.
42. De Haes W, Van Mol G, Merlin C, De Smedt SC, Vanham G, Rejman J. Internalization of mRNA lipoplexes by dendritic cells. Mol Pharm 2012; 9: 2942-2949.
43. Vandenbroucke RE, De Smedt SC, Demeester J, Sanders NN. Cellular entry pathway and gene transfer capacity of TAT-modified lipoplexes. Biochim Biophys Acta 2007; 1768: 571-579.
44. Sabharanjak S, Sharma P, Parton RG, Mayor S. GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev Cell 2002; 2: 411-423.
45. Howes MT, Kirkham M, Riches J, et al. Clathrin-independent carriers form a high capacity endocytic sorting system at the leading edge of migrating cells. J Cell Biol 2010; 190: 675-691.
46. Nakase I, Niwa M, Takeuchi T, et al. Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther 2004; 10: 1011-1022.
47. Biegeleisen K. The probable structure of the protamine-DNA complex. J Theor Biol 2006; 241: 533-540.
48. Medina-Kauwe LK, Xie J, Hamm-Alvarez S. Intracellular trafficking of nonviral vectors. Gene Ther 2005; 12: 1734-1751.
49. Wattiaux R, Jadot M, Warnier-Pirotte MT, Wattiaux-De CS. Cationic lipids destabilize lysosomal membrane in vitro. FEBS Lett 1997; 417: 199-202.
50. Kerr MC, Teasdale RD. Defining macropinocytosis. Traffic 2009; 10: 364-371.
51. Ellinger I, Fuchs R. Receptor-mediated and fluid-phase transcytosis of horseradish peroxidase across rat hepatocytes. J Biomed Biotechnol 2010; 2010: 850320.
52. Racoosin EL, Swanson JA. Macropinosome maturation and fusion with tubular lysosomes in macrophages. J Cell Biol 1993; 121: 1011-1020.